OxTalks is Changing
On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Virtual Public talk: Surgery or stents – which is more effective in preventing stroke?
Stroke is the second largest cause of death worldwide, responsible for over six million deaths each year. A common cause of stroke is carotid artery disease, which can be treated in one of two ways: carotid artery surgery; or having a stent fitted, with a view to improving blood flow to the brain. Until recently, it has been unclear which of these procedures results in better overall patient outcomes.
To answer this question, researchers at Nuffield Department of Population Health at the University of Oxford have coordinated the Asymptomatic Carotid Surgery Trial 2 (ACST-2), the largest trial to date comparing the outcomes of the 2 procedures.
In this talk, research fellow and consultant vascular surgeon Richard Bulbulia will discuss the findings of the ACST-2 trial and whether patient factors favour one approach over another when treating those at risk of a stroke.
Date:
12 October 2022, 13:00
Venue:
https://zoom.us/j/99450712016?pwd=QlIxaEhSNWZkT1VQTUJpTUltRmV4UT09
Speaker:
Richard Bulbulia (Nuffield Department of Population Health)
Organiser:
NIHR Oxford Biomedical Research Centre
Organiser contact email address:
sarah.marr@ouh.nhs.uk
Booking required?:
Not required
Audience:
Public
Editor:
Janice Young
